EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Diagnosing primary immunodeficiencies using protein-based screening assays

Micol Ferro iD, Mercedes Selby, Mark Davis, Kimberly Gilmour

Clinical and Experimental Immunology · 2026

DOI: 10.1093/cei/uxag062 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Experimental Immunology, 2026. Verfasst von Micol Ferro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Camelia Botnar Laboratories, Department of Immunology, Great Ormond Street Hospital (GOSH), London UK. Hauptthemen laut MEDLINE: Immunologic Deficiency Syndromes. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute for Health and Care Research, NIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary immunodeficiencies, now more commonly referred to as inborn errors of immunity (IEIs), are a diverse group of inherited conditions characterized by immune system defects, leading to recurrent infections, immune dysregulation, and autoimmune symptoms. Early diagnosis is crucial for effective management and treatment. This document explores the role of protein-based assays in diagnosing and characterizing IEIs. Protein-based assays, including enzyme-linked immunosorbent assay (ELISA), flow cytometry, and immunoblotting, have significantly advanced the identification and understanding of IEI. These assays enable rapid screening and functional analysis of immune proteins, providing critical insights into the phenotypic manifestations of genetic mutations. ELISA technology allows for the detection of specific antigens or antibodies, while flow cytometry facilitates the analysis of multiple cell populations and their functional states. Immunoblotting remains valuable for detecting protein expression and identifying truncated or non-functional proteins. This review highlights case studies demonstrating the application of these assays in diagnosing conditions such as X-linked lymphoproliferative syndrome type 2, activated phosphoinositide 3-kinase delta syndrome, severe combined immunodeficiency, and Wiskott–Aldrich syndrome. It also discusses the importance of functional assays in confirming the pathogenicity of genetic variants of unknown significance and guiding targeted genetic analysis. Overall, protein-based assays are essential tools in the diagnostic workflow for IEI, enabling timely and accurate diagnosis, guiding therapeutic decisions, and monitoring patient outcomes post-treatment, including haematopoietic stem cell transplantation and gene therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunologic Deficiency SyndromesHumansEnzyme-Linked Immunosorbent AssayFlow CytometryWiskott-Aldrich SyndromePrimary Immunodeficiency DiseasesClass I Phosphatidylinositol 3-Kinases

Stichwörter der Autor:innen

diagnosticsinborn error of immunity (IEI)primary immunodeficiency (PID)research and development (R&D)translational assays

Substanzen

Class I Phosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Camelia Botnar Laboratories, Department of Immunology, Great Ormond Street Hospital (GOSH), London UK.

ORCID-Profile: Micol Ferro

Förderung

  • National Institute for Health and Care Research
  • NIHR

Zitieren

APA

Ferro, M., Selby, M., Davis, M., & Gilmour, K. (2026). Diagnosing primary immunodeficiencies using protein-based screening assays. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxag062

Vancouver

Ferro M, Selby M, Davis M, Gilmour K. Diagnosing primary immunodeficiencies using protein-based screening assays. Clinical and Experimental Immunology. 2026. doi:10.1093/cei/uxag062

BibTeX
@article{Ferro2026,
  author = {Ferro, Micol and Selby, Mercedes and Davis, Mark and Gilmour, Kimberly},
  title = {Diagnosing primary immunodeficiencies using protein-based screening assays},
  journal = {Clinical and Experimental Immunology},
  year = {2026},
  doi = {10.1093/cei/uxag062}
}
Kostenlos starten →